FDA Approved Medical Products for:

Mucopolysaccharidosis type VI

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name N-acetylgalactosamine-4-sulfatase, recombinant human
Trade Name
(Manufacturer Name)
Naglazyme®
(BioMarin Pharmaceutical, Inc.)
Indication
The FDA has approved this product to be used in this manner.
For patients with mucopolysaccharidosis VI. Galsulfase has been shown to improve walking and stair-climbing capacity.
More Information about this product Drug Information Portal